Lise El Omari: Join Us for a Free Gynea Webinar to Take Stock of Ovarian Masses on Ultrasound
Lise El Omari, Medical Director at Gynea, President of URPS Midwives Ile-de-France, shared a post by Gynea on LinkedIn:
“Free Gynea Webinar – 1 hour to take stock of ovarian masses on ultrasound!
I will be alongside Jean-Marc Levaillant , expert, co-president of the GREEG Research and Teaching Group in Gynecological Ultrasound and head of the DU ‘Ultrasound Exploration of Fertility’ at the University of Paris-Est Créteil to lead this one-hour webinar dedicated to the ultrasound classification of ovarian masses.
Whether you perform dating ultrasound in the context of abortion, obstetric or pelvic ultrasound, you have certainly already been confronted with an ovarian mass.
Functional cyst, corpus luteum, endometrioma, dermoid cyst, malignant tumor… This will be an opportunity to take stock of the precise tools for description and diagnosis assistance, based on concrete cases.
Meet us at lunchtime: come share your snack with us and chat with other practitioners!
A friendly and enriching moment, for both young practitioners and experienced sonographers.
Free registration here.”
Quoting Gynea’s post:
“The evaluation of ovarian masses remains a daily challenge in gynaecological imaging, between the need not to ignore a malignant pathology and the risk of over-treating benign lesions.
We are pleased to organize a webinar in collaboration with Jean-Marc Levaillant, obstetrician-gynecologist and head of the University Diploma ‘Ultrasound Exploration of Fertility’ in Créteil, to help sonographers better qualify these ovarian masses.
On the program:
- Know how to recognize the main benign ovarian masses
- Use simple criteria in a relevant way
- Define a course of action to be taken in the face of an unclassifiable mass
- Discover diagnostic tools
The webinar will be hosted by Lise El Omari Medical Director at Gynea. To register, go to the link in the comments.
Fellow sonographers, save the date!”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 06:53New Data on Assisted Hatching in Assisted Reproduction – C.L.A.R. Consulting
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility